Understanding the Sortino Ratio: A Key Metric for Risk-Adjusted Investment Performance
Finance

Understanding the Sortino Ratio: A Key Metric for Risk-Adjusted Investment Performance

authorBy Robert Kiyosaki
DateJul 22, 2026
Read time2 min

The Sortino ratio is a key metric in investment analysis, offering a refined way to measure risk-adjusted returns. It primarily focuses on an investment's exposure to negative volatility, or "bad risk," distinguishing it from other performance indicators that consider all forms of volatility, including beneficial upward movements. This specialized focus helps investors and analysts to more accurately gauge how well an investment generates returns relative to the risk of losing money.

To utilize this ratio effectively, it is essential to understand its calculation: the difference between the actual or expected portfolio return and the risk-free rate, divided by the standard deviation of the downside. A higher result from this calculation is indicative of better performance, signifying that the investment yields greater returns for each unit of undesirable risk taken. For instance, when comparing two investments, the one with a superior Sortino ratio is generally preferred, as it demonstrates a more efficient generation of returns given its exposure to negative fluctuations. Therefore, the Sortino ratio provides a comprehensive perspective on an investment's true risk-adjusted performance by isolating and evaluating the impact of detrimental market movements.

The Sortino ratio enhances traditional risk assessment by differentiating between good and bad volatility. By concentrating solely on the risk of losses, it provides a more intuitive and actionable measure for investors. This approach helps in making informed decisions by prioritizing investments that offer stronger returns while prudently managing the potential for negative outcomes.

More Articles
Finance
Mastering Diagonal Spreads: A Comprehensive Options Trading Guide
A diagonal spread is an advanced options trading strategy that blends elements of both vertical and horizontal spreads. It involves combining options with different strike prices and expiration dates to manage risk, reduce time decay, and position for specific market movements. This versatile approach allows traders to implement either bullish or bearish stances, often by purchasing a longer-dated option and selling a shorter-dated one. Understanding its mechanics, types, and practical application is key to leveraging this strategy effectively.
By Lisa JingJul 22, 2026
Finance
The Looming Natural Gas Surge: Investment Opportunities Amidst AI and Energy Demand
As artificial intelligence (AI) drives a surge in power demand, the market's focus is shifting from oil to natural gas. Matthew Smith, Chief Investment Officer at Chronometer Partners, highlights natural gas as a critical investment opportunity. He anticipates a significant increase in natural gas exports and a deficit by 2030, presenting a unique moment for investors to capitalize on this evolving energy landscape.
By Michele FerreroJul 22, 2026
Finance
KBWY: A High-Yielding Small And Mid-Cap REIT ETF Offers Market-Beating Returns
The Invesco KBW Premium Yield Equity REIT ETF (KBWY) has delivered a robust 29% total return in 2026, outperforming broader REIT indices. This success is attributed to its strategic focus on high-yielding small and mid-cap REITs across diverse sectors like healthcare and office. The ETF benefits from favorable market conditions, including anticipated rate cuts, strong FFO growth, and increasing demand in specialized property types. Despite higher volatility due to its small/mid-cap exposure, KBWY's 8% monthly dividend yield and strong quant scores make it an attractive investment, warranting a buy rating.
By Nouriel RoubiniJul 22, 2026
Finance
Orchestra BioMed: A Promising Horizon in Medical Device Innovation
Orchestra BioMed is on the cusp of major clinical trial readouts for its AVIM Therapy and Virtue SAB, both showing high potential for success. The company functions as a hub for medical device innovation and development, supported by key commercialization partnerships with Medtronic and Terumo. With substantial investments from these partners, OBIO's current valuation offers considerable upside as these critical catalysts approach, particularly with upcoming trial data expected in Q2 2027 and 2028, ensuring funding until Q4 2027.
By Morgan HouselJul 22, 2026
Finance
Analyzing the Calamos Convertible & High-Income Fund (CHY)
The Calamos Convertible & High-Income Fund (CHY) offers investors exposure to income-generating securities with a notable 9.2% dividend yield. While its performance is strong, driven primarily by net realized gains rather than net investment income, this raises sustainability questions, especially in potential market downturns or rising interest rate environments. The fund's significant allocation to the technology sector and substantial leverage (31.54% of assets) introduce both heightened growth opportunities and increased risk. Given that most distributions originate from short-term gains, CHY is ideally suited for tax-advantaged accounts to mitigate higher tax liabilities.
By Fareed ZakariaJul 22, 2026